Skip to main content
SpringerLink
Log in

Age-Related Macular Degeneration: Epidemiology and Clinical Aspects

  • Chapter
  • First Online:
Age-related Macular Degeneration

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1256))

Abstract

Age-related macular degeneration (AMD) is a degenerative disease of the human retina affecting individuals over the age of 55 years. This heterogeneous condition arises from a complex interplay between age, genetics, and environmental factors including smoking and diet. It is the leading cause of blindness in industrialized countries. Worldwide, the number of people with AMD is predicted to increase from 196 million in 2020 to 288 million by 2040. By this time, Asia is predicted to have the largest number of people with the disease. Distinct patterns of AMD prevalence and phenotype are seen between geographical areas that are not explained fully by disparities in population structures. AMD is classified into early, intermediate, and late stages. The early and intermediate stages, when visual symptoms are typically absent or mild, are characterized by macular deposits (drusen) and pigmentary abnormalities. Through risk prediction calculators, grading these features helps predict the risk of progression to late AMD. Late AMD is divided into neovascular and atrophic forms, though these can coexist. The defining lesions are macular neovascularization and geographic atrophy, respectively. At this stage, visual symptoms are often severe and irreversible, and can comprise profoundly decreased central vision in both eyes. For these reasons, the condition has major implications for individuals and society, as affected individuals may experience substantially decreased quality of life and independence. Recent advances in retinal imaging have led to the recognition of an expanded set of AMD phenotypes, including reticular pseudodrusen, nonexudative macular neovascularization, and subtypes of atrophy. These developments may lead to refinements in current classification systems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY et al (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2(2):e106–e116

    Article  PubMed  Google Scholar 

  2. Jonas JB, Cheung CMG, Panda-Jonas S (2017) Updates on the epidemiology of age-related macular degeneration. Asia Pac J Ophthalmol (Phila) 6(6):493–497

    Google Scholar 

  3. Congdon N, O’Colmain B, Klaver CC, Klein R, Munoz B, Friedman DS et al (2004) Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122(4):477–485

    Article  PubMed  Google Scholar 

  4. Quartilho A, Simkiss P, Zekite A, Xing W, Wormald R, Bunce C (2016) Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013. Eye (Lond) 30(4):602–607

    Article  CAS  Google Scholar 

  5. Ratnapriya R, Chew EY (2013) Age-related macular degeneration-clinical review and genetics update. Clin Genet 84(2):160–166

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Cimarolli VR, Casten RJ, Rovner BW, Heyl V, Sorensen S, Horowitz A (2016) Anxiety and depression in patients with advanced macular degeneration: current perspectives. Clin Ophthalmol 10:55–63

    PubMed  Google Scholar 

  7. Coleman AL, Yu F, Ensrud KE, Stone KL, Cauley JA, Pedula KL et al (2010) Impact of age-related macular degeneration on vision-specific quality of life: follow-up from the 10-year and 15-year visits of the study of osteoporotic fractures. Am J Ophthalmol 150(5):683–691

    Article  PubMed  PubMed Central  Google Scholar 

  8. Bonastre J, Le Pen C, Anderson P, Ganz A, Berto P, Berdeaux G (2002) The epidemiology, economics and quality of life burden of age-related macular degeneration in France, Germany, Italy and the United Kingdom. Eur J Health Econ 3(2):94–102

    Article  CAS  PubMed  Google Scholar 

  9. Casten RJ, Rovner BW (2013) Update on depression and age-related macular degeneration. Curr Opin Ophthalmol 24(3):239–243

    Article  PubMed  PubMed Central  Google Scholar 

  10. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L (1991) The Wisconsin age-related maculopathy grading system. Ophthalmology 98(7):1128–1134

    Article  CAS  PubMed  Google Scholar 

  11. Klein R, Klein BE, Linton KL (1992) Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99(6):933–943

    Article  CAS  PubMed  Google Scholar 

  12. Klein R, Klein BE, Jensen SC, Meuer SM (1997) The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104(1):7–21

    Article  CAS  PubMed  Google Scholar 

  13. Heiba IM, Elston RC, Klein BE, Klein R (1994) Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol 11(1):51–67

    Article  CAS  PubMed  Google Scholar 

  14. Klein R, Klein BE, Linton KL, DeMets DL (1993) The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 137(2):190–200

    Article  CAS  PubMed  Google Scholar 

  15. Klein R, Klein BE, Franke T (1993) The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 100(3):406–414

    Article  CAS  PubMed  Google Scholar 

  16. Cruickshanks KJ, Klein R, Klein BE (1993) Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol 111(4):514–518

    Article  CAS  PubMed  Google Scholar 

  17. Mitchell P, Smith W, Attebo K, Wang JJ (1995) Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102(10):1450–1460

    Article  CAS  PubMed  Google Scholar 

  18. Wang JJ, Foran S, Smith W, Mitchell P (2003) Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol 121(5):658–663

    Article  PubMed  Google Scholar 

  19. Smith W, Mitchell P, Leeder SR (1996) Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol 114(12):1518–1523

    Article  CAS  PubMed  Google Scholar 

  20. Smith W, Mitchell P, Leeder SR, Wang JJ (1998) Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 116(5):583–587

    Article  CAS  PubMed  Google Scholar 

  21. Smith W, Mitchell P (1998) Family history and age-related maculopathy: the Blue Mountains Eye Study. Aust N Z J Ophthalmol 26(3):203–206

    Article  CAS  PubMed  Google Scholar 

  22. Age-Related Eye Disease Study Research Group (1999) The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. Control Clin Trials 20(6):573–600

    Article  Google Scholar 

  23. AREDS RG (2001) The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study report number 6. Am J Ophthalmol 132(5):668–681

    Article  Google Scholar 

  24. AREDS RG (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119(10):1417–1436

    Article  Google Scholar 

  25. AREDS (2000) Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: age-related eye disease study report number 3. Ophthalmology 107(12):2224–2232

    Google Scholar 

  26. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL, Age-Related Eye Disease Study Research Group (2005) Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS) AREDS report no. 19. Ophthalmology 112(4):533–539

    Article  PubMed  Google Scholar 

  27. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N (2004) Association between C-reactive protein and age-related macular degeneration. JAMA 291(6):704–710

    Article  CAS  PubMed  Google Scholar 

  28. Ferris FL, Davis MD, Clemons TE, Lee LY, Chew EY, Lindblad AS et al (2005) A simplified severity scale for age-related macular degeneration: AREDS report no. 18. Arch Ophthalmol 123(11):1570–1574

    Article  PubMed  Google Scholar 

  29. Vitale S, Clemons TE, Agron E, Ferris FL 3rd, Domalpally A, Danis RP et al (2016) Evaluating the validity of the age-related eye disease study grading scale for age-related macular degeneration: AREDS2 report 10. JAMA Ophthalmol 134(9):1041–1047

    Article  PubMed  PubMed Central  Google Scholar 

  30. Liew G, Joachim N, Mitchell P, Burlutsky G, Wang JJ (2016) Validating the AREDS simplified severity scale of age-related macular degeneration with 5- and 10-year incident data in a population-based sample. Ophthalmology 123(9):1874–1878

    Article  PubMed  Google Scholar 

  31. AREDS2 Research Group, Chew EY, Clemons T, SanGiovanni JP, Danis R, Domalpally A et al (2012) The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology 119(11):2282–2289

    Article  Google Scholar 

  32. Klein R, Klein BE, Cruickshanks KJ (1999) The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res 18(3):371–389

    Article  CAS  PubMed  Google Scholar 

  33. Fisher DE, Klein BE, Wong TY, Rotter JI, Li X, Shrager S et al (2016) Incidence of age-related macular degeneration in a multi-ethnic United States population: the multi-ethnic study of atherosclerosis. Ophthalmology 123(6):1297–1308

    Article  PubMed  Google Scholar 

  34. Reibaldi M, Longo A, Pulvirenti A, Avitabile T, Russo A, Cillino S et al (2016) Geo-epidemiology of age-related macular degeneration: new clues into the pathogenesis. Am J Ophthalmol 161:78–93

    Article  PubMed  Google Scholar 

  35. Goldacre RR, Keenan TDL (2017) Age-related maculopathy-degeneration by generation. JAMA Ophthalmol 135(12):1424–1425

    Article  PubMed  Google Scholar 

  36. Cruickshanks KJ, Nondahl DM, Johnson LJ, Dalton DS, Fisher ME, Huang GH et al (2017) Generational differences in the 5-year incidence of age-related macular degeneration. JAMA Ophthalmol 135(12):1417–1423

    Article  PubMed  PubMed Central  Google Scholar 

  37. Colijn JM, Buitendijk GHS, Prokofyeva E, Alves D, Cachulo ML, Khawaja AP et al (2017) Prevalence of age-related macular degeneration in Europe: the past and the future. Ophthalmology 124(12):1753–1763

    Article  PubMed  Google Scholar 

  38. Klein R, Meuer SM, Myers CE, Buitendijk GH, Rochtchina E, Choudhury F et al (2014) Harmonizing the classification of age-related macular degeneration in the three-continent AMD consortium. Ophthalmic Epidemiol 21(1):14–23

    Article  PubMed  PubMed Central  Google Scholar 

  39. Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K et al (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120(4):844–851

    Article  PubMed  Google Scholar 

  40. Ardeljan D, Chan CC (2013) Aging is not a disease: distinguishing age-related macular degeneration from aging. Prog Retin Eye Res 37:68–89

    Article  CAS  PubMed  Google Scholar 

  41. Keenan TD, Agron E, Domalpally A, Clemons TE, van Asten F, Wong WT et al (2018) Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16. Ophthalmology 125(12):1913–1928

    Article  PubMed  Google Scholar 

  42. van Asten F, Simmons M, Singhal A, Keenan TD, Ratnapriya R, Agron E et al (2018) A deep phenotype association study reveals specific phenotype associations with genetic variants in age-related macular degeneration: Age-Related Eye Disease Study 2 (AREDS2) report no. 14. Ophthalmology 125(4):559–568

    Article  PubMed  Google Scholar 

  43. Jabbarpoor Bonyadi MH, Yaseri M, Nikkhah H, Bonyadi M, Soheilian M (2018) Association of risk genotypes of ARMS2/LOC387715 A69S and CFH Y402H with age-related macular degeneration with and without reticular pseudodrusen: a meta-analysis. Acta Ophthalmol 96(2):e105–ee10

    Article  CAS  PubMed  Google Scholar 

  44. Khan KN, Mahroo OA, Khan RS, Mohamed MD, McKibbin M, Bird A et al (2016) Differentiating drusen: Drusen and drusen-like appearances associated with ageing, age-related macular degeneration, inherited eye disease and other pathological processes. Prog Retin Eye Res 53:70–106

    Article  CAS  PubMed  Google Scholar 

  45. Spaide RF, Ooto S, Curcio CA (2018) Subretinal drusenoid deposits AKA pseudodrusen. Surv Ophthalmol. https://doi.org/10.1016/j.survophthal.2018.05.005

  46. Sivaprasad S, Bird A, Nitiahpapand R, Nicholson L, Hykin P, Chatziralli I et al (2016) Perspectives on reticular pseudodrusen in age-related macular degeneration. Surv Ophthalmol 61(5):521–537

    Article  PubMed  Google Scholar 

  47. Davis MD, Gangnon RE, Lee LY, Hubbard LD, Klein BE, Klein R et al (2005) The age-related eye disease study severity scale for age-related macular degeneration: AREDS report no. 17. Arch Ophthalmol 123(11):1484–1498

    Article  PubMed  Google Scholar 

  48. Mimoun G, Soubrane G, Coscas G (1990) Macular drusen. J Fr Ophtalmol 13(10):511–530

    CAS  PubMed  Google Scholar 

  49. Flamendorf J, Agron E, Wong WT, Thompson D, Wiley HE, Doss EL et al (2015) Impairments in dark adaptation are associated with age-related macular degeneration severity and reticular pseudodrusen. Ophthalmology 122(10):2053–2062

    Article  PubMed  Google Scholar 

  50. Roisman L, Zhang Q, Wang RK, Gregori G, Zhang A, Chen CL et al (2016) Optical coherence tomography angiography of asymptomatic neovascularization in intermediate age-related macular degeneration. Ophthalmology 123(6):1309–1319

    Article  PubMed  Google Scholar 

  51. de Oliveira Dias JR, Zhang Q, Garcia JMB, Zheng F, Motulsky EH, Roisman L et al (2018) Natural history of subclinical neovascularization in nonexudative age-related macular degeneration using swept-source OCT angiography. Ophthalmology 125(2):255–266

    Article  PubMed  Google Scholar 

  52. Writing Committee for the OPRs, Domalpally A, Clemons TE, Danis RP, Sadda SR, Cukras CA et al (2017) Peripheral retinal changes associated with age-related macular degeneration in the age-related eye disease study 2: age-related eye disease study 2 report number 12 by the age-related eye disease study 2 Optos PEripheral RetinA (OPERA) Study Research Group. Ophthalmology 124(4):479–487

    Article  Google Scholar 

  53. Bird AC, Bok D (2017) Why the macula? Eye (Lond) 32(5):858–862

    Article  Google Scholar 

  54. Munoz B, West SK, Rubin GS, Schein OD, Quigley HA, Bressler SB et al (2000) Causes of blindness and visual impairment in a population of older Americans: the Salisbury Eye Evaluation Study. Arch Ophthalmol 118(6):819–825

    Article  CAS  PubMed  Google Scholar 

  55. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF et al (1995) The prevalence of age-related maculopathy in the Rotterdam study. Ophthalmology 102(2):205–210

    Article  CAS  PubMed  Google Scholar 

  56. Weih LM, VanNewkirk MR, McCarty CA, Taylor HR (2000) Age-specific causes of bilateral visual impairment. Arch Ophthalmol 118(2):264–269

    Article  CAS  PubMed  Google Scholar 

  57. Pang L (2016) Hallucinations experienced by visually impaired: Charles Bonnet Syndrome. Optom Vis Sci 93(12):1466–1478

    Article  PubMed  PubMed Central  Google Scholar 

  58. Spaide RF (2018) Improving the age-related macular degeneration construct: a new classification system. Retina 38(5):891–899

    Article  PubMed  Google Scholar 

  59. Chong NH, Keonin J, Luthert PJ, Frennesson CI, Weingeist DM, Wolf RL et al (2005) Decreased thickness and integrity of the macular elastic layer of Bruch’s membrane correspond to the distribution of lesions associated with age-related macular degeneration. Am J Pathol 166(1):241–251

    Article  PubMed  PubMed Central  Google Scholar 

  60. Tan ACS, Simhaee D, Balaratnasingam C, Dansingani KK, Yannuzzi LA (2016) A perspective on the nature and frequency of pigment epithelial detachments. Am J Ophthalmol 172:13–27

    Article  PubMed  Google Scholar 

  61. Cukras C, Agron E, Klein ML, Ferris FL 3rd, Chew EY, Gensler G et al (2010) Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study report no. 28. Ophthalmology 117(3):489–499

    Article  PubMed  Google Scholar 

  62. Yu JJ, Agromicronn E, Clemons TE, Domalpally A, van Asten F, Keenan TD et al (2018) Natural history of drusenoid pigment epithelial detachment associated with age-related macular degeneration: Age-Related Eye Disease Study 2 Report No. 17. Ophthalmology. https://doi.org/10.1016/j.ophtha.2009.12.002

  63. Miller JW (2013) Age-related macular degeneration revisited – piecing the puzzle: the LXIX Edward Jackson Memorial Lecture. Am J Ophthalmol 155(1):1–35

    Article  PubMed  Google Scholar 

  64. Ying GS, Maguire MG, Pan W, Grunwald JE, Daniel E, Jaffe GJ et al (2018) Baseline predictors for five-year visual acuity outcomes in the comparison of AMD treatment trials. Ophthalmol Retina 2(6):525–530

    Article  PubMed  PubMed Central  Google Scholar 

  65. Lee AY, Lee CS, Butt T, Xing W, Johnston RL, Chakravarthy U et al (2015) UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12. Br J Ophthalmol 99(8):1045–1050

    Article  PubMed  Google Scholar 

  66. Chew EY, Clemons TE, Bressler SB, Elman MJ, Danis RP, Domalpally A et al (2014) Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design - HOME study report number 1. Contemp Clin Trials 37(2):294–300

    Article  PubMed  Google Scholar 

  67. Schmidt-Erfurth U, Waldstein SM (2016) A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration. Prog Retin Eye Res 50:1–24

    Article  CAS  PubMed  Google Scholar 

  68. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol (1982) 100(6):912–918

    Google Scholar 

  69. Tsai AS, Cheung N, Gan AT, Jaffe GJ, Sivaprasad S, Wong TY et al (2017) Retinal angiomatous proliferation. Surv Ophthalmol 62(4):462–492

    Article  PubMed  Google Scholar 

  70. Ravera V, Bottoni F, Giani A, Cigada M, Staurenghi G (2016) Retinal angiomatous proliferation diagnosis: a multiimaging approach. Retina 36(12):2274–2281

    Article  PubMed  Google Scholar 

  71. Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB et al (2018) Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology 125(5):708–724

    Article  PubMed  Google Scholar 

  72. Dansingani KK, Gal-Or O, Sadda SR, Yannuzzi LA, Freund KB (2018) Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of ‘expanded spectra’ - a review. Clin Exp Ophthalmol 46(2):189–200

    Article  PubMed  Google Scholar 

  73. Liang S, Shi X, Rosenfeld PJ, Li X (2018) Type 2 choroidal neovascularisation in polypoidal choroidal vasculopathy: a retrospective case series. Br J Ophthalmol. https://doi.org/10.1136/bjophthalmol-2017-311518

  74. Gass JD (1973) Drusen and disciform macular detachment and degeneration. Arch Ophthalmol 90(3):206–217

    Article  CAS  PubMed  Google Scholar 

  75. Bird AC, Phillips RL, Hageman GS (2014) Geographic atrophy: a histopathological assessment. JAMA Ophthalmol 132(3):338–345

    Article  PubMed  PubMed Central  Google Scholar 

  76. Rudnicka AR, Kapetanakis VV, Jarrar Z, Wathern AK, Wormald R, Fletcher AE et al (2015) Incidence of late-stage age-related macular degeneration in American whites: systematic review and meta-analysis. Am J Ophthalmol 160(1):85–93. e3

    Article  PubMed  Google Scholar 

  77. Sunness JS (2008) Face fields and microperimetry for estimating the location of fixation in eyes with macular disease. J Vis Impair Blind 102(11):679–689

    Article  PubMed  PubMed Central  Google Scholar 

  78. Schmitz-Valckenberg S, Sadda S, Staurenghi G, Chew EY, Fleckenstein M, Holz FG et al (2016) Geographic atrophy: semantic considerations and literature review. Retina 36(12):2250–2264

    Article  PubMed  PubMed Central  Google Scholar 

  79. Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP et al (2013) Methods and reproducibility of grading optimized digital color fundus photographs in the age-related eye disease study 2 (AREDS2 report number 2). Invest Ophthalmol Vis Sci 54(7):4548–4554

    Article  PubMed  PubMed Central  Google Scholar 

  80. Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Martin DF et al (2015) Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 122(4):809–816

    Article  PubMed  Google Scholar 

  81. Sadda SR, Tuomi LL, Ding B, Fung AE, Hopkins JJ (2018) Macular Atrophy in the HARBOR study for neovascular age-related macular degeneration. Ophthalmology 125(6):878–886

    Article  PubMed  Google Scholar 

  82. Zarbin MA, Casaroli-Marano RP, Rosenfeld PJ (2014) Age-related macular degeneration: clinical findings, histopathology and imaging techniques. Dev Ophthalmol 53:1–32

    Article  PubMed  Google Scholar 

  83. Danis RP, Lavine JA, Domalpally A (2015) Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects. Clin Ophthalmol 9:2159–2174

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Holz FG, Bindewald-Wittich A, Fleckenstein M, Dreyhaupt J, Scholl HP, Schmitz-Valckenberg S (2007) Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol 143(3):463–472

    Article  PubMed  Google Scholar 

  85. Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC et al (2017) Consensus definition for Atrophy associated with age-related macular degeneration on OCT: classification of Atrophy report 3. Ophthalmology. https://doi.org/10.1016/j.ophtha.2017.09.028

  86. Sadda SR, Chakravarthy U, Birch DG, Staurenghi G, Henry EC, Brittain C (2016) Clinical endpoints for the study of geographic atrophy secondary to age-related macular degeneration. Retina 36(10):1806–1822

    Article  PubMed  PubMed Central  Google Scholar 

  87. Thiele S, Pfau M, Larsen PP, Fleckenstein M, Holz FG, Schmitz-Valckenberg S (2018) Multimodal imaging patterns for development of central atrophy secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci 59(4):AMD1–AMD11

    Article  PubMed  Google Scholar 

  88. Wu Z, Luu CD, Ayton LN, Goh JK, Lucci LM, Hubbard WC et al (2014) Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration. Ophthalmology 121(12):2415–2422

    Article  PubMed  Google Scholar 

  89. Klein ML, Ferris FL 3rd, Armstrong J, Hwang TS, Chew EY, Bressler SB et al (2008) Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology 115(6):1026–1031

    Article  PubMed  Google Scholar 

  90. Feuer WJ, Yehoshua Z, Gregori G, Penha FM, Chew EY, Ferris FL et al (2013) Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of age-related eye disease study report no. 26. JAMA Ophthalmol 131(1):110–111

    Article  PubMed  Google Scholar 

  91. Fleckenstein M, Mitchell P, Freund KB, Sadda S, Holz FG, Brittain C et al (2018) The progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology 125(3):369–390

    Article  PubMed  Google Scholar 

  92. Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG (2012) Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119(3):571–580

    Article  PubMed  Google Scholar 

  93. Winkler TW, Brandl C, Grassmann F, Gorski M, Stark K, Loss J et al (2018) Investigating the modulation of genetic effects on late AMD by age and sex: lessons learned and two additional loci. PLoS One 13(3):e0194321

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  94. Keenan TD, Toso M, Pappas C, Nichols L, Bishop PN, Hageman GS (2015) Assessment of proteins associated with complement activation and inflammation in maculae of human donors homozygous risk at chromosome 1 CFH-to-F13B. Invest Ophthalmol Vis Sci 56(8):4870–4879

    Article  CAS  PubMed  Google Scholar 

  95. Fritsche LG, Fariss RN, Stambolian D, Abecasis GR, Curcio CA, Swaroop A (2014) Age-related macular degeneration: genetics and biology coming together. Annu Rev Genomics Hum Genet 15:151–171

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Sobrin L, Seddon JM (2014) Nature and nurture- genes and environment- predict onset and progression of macular degeneration. Prog Retin Eye Res 40:1–15

    Article  PubMed  Google Scholar 

  97. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI et al (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102(20):7227–7232

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C et al (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308(5720):385–389

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P et al (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308(5720):419–421

    Article  CAS  PubMed  Google Scholar 

  100. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308(5720):421–424

    Article  CAS  PubMed  Google Scholar 

  101. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB (2005) Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 77(3):389–407

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger T et al (2005) Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 14(21):3227–3236

    Article  CAS  PubMed  Google Scholar 

  103. Fritsche LG, Igl W, Bailey JN, Grassmann F, Sengupta S, Bragg-Gresham JL et al (2016) A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet 48(2):134–143

    Article  CAS  PubMed  Google Scholar 

  104. Liu MM, Chan CC, Tuo J (2012) Genetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics. Hum Genomics 6:13

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  105. Grassmann F, Cantsilieris S, Schulz-Kuhnt AS, White SJ, Richardson AJ, Hewitt AW et al (2016) Multiallelic copy number variation in the complement component 4A (C4A) gene is associated with late-stage age-related macular degeneration (AMD). J Neuroinflammation 13(1):81

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  106. Oliver VF, Jaffe AE, Song J, Wang G, Zhang P, Branham KE et al (2015) Differential DNA methylation identified in the blood and retina of AMD patients. Epigenetics 10(8):698–707

    Article  PubMed  PubMed Central  Google Scholar 

  107. Woodell A, Rohrer B (2014) A mechanistic review of cigarette smoke and age-related macular degeneration. Adv Exp Med Biol 801:301–307

    Article  PubMed  Google Scholar 

  108. Lambert NG, ElShelmani H, Singh MK, Mansergh FC, Wride MA, Padilla M et al (2016) Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res 54:64–102

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G et al (2010) Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 10:31

    Article  PubMed  PubMed Central  Google Scholar 

  110. Ehmann DS, Ho AC (2017) Cataract surgery and age-related macular degeneration. Curr Opin Ophthalmol 28(1):58–62

    Article  PubMed  Google Scholar 

  111. Chew EY, Sperduto RD, Milton RC, Clemons TE, Gensler GR, Bressler SB et al (2009) Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25. Ophthalmology 116(2):297–303

    Article  PubMed  Google Scholar 

  112. Hooper CY, Lamoureux EL, Lim L, Fraser-Bell S, Yeoh J, Harper CA et al (2009) Cataract surgery in high-risk age-related macular degeneration: a randomized controlled trial. Clin Exp Ophthalmol 37(6):570–576

    Article  PubMed  Google Scholar 

  113. Ding Y, Liu Y, Yan Q, Fritsche LG, Cook RJ, Clemons T et al (2017) Bivariate analysis of age-related macular degeneration progression using genetic risk scores. Genetics 206(1):119–133

    Article  PubMed  PubMed Central  Google Scholar 

  114. Myers CE, Klein BE, Gangnon R, Sivakumaran TA, Iyengar SK, Klein R (2014) Cigarette smoking and the natural history of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 121(10):1949–1955

    Article  PubMed  Google Scholar 

  115. Gorusupudi A, Nelson K, Bernstein PS (2017) The Age-Related Eye Disease 2 Study: micronutrients in the treatment of macular degeneration. Adv Nutr 8(1):40–53

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Zampatti S, Ricci F, Cusumano A, Marsella LT, Novelli G, Giardina E (2014) Review of nutrient actions on age-related macular degeneration. Nutr Res 34(2):95–105

    Article  CAS  PubMed  Google Scholar 

  117. Age-Related Eye Disease Study Research Group, JP SG, Chew EY, Clemons TE, Ferris FL, Gensler G et al (2007) The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol 125(9):1225–1232

    Article  Google Scholar 

  118. Merle BM, Colijn JM, Cougnard-Gregoire A, de Koning-Backus APM, Delyfer MN, Kiefte-de Jong JC et al (2018) Mediterranean diet and incidence of advanced AMD: the EYE-RISK consortium. Ophthalmology 126(3):381–390

    Article  PubMed  Google Scholar 

  119. Nunes S, Alves D, Barreto P, Raimundo M, da Luz CM, Farinha C et al (2018) Adherence to a Mediterranean diet and its association with age-related macular degeneration. The Coimbra Eye Study-Report 4. Nutrition 51–52:6–12

    Article  PubMed  Google Scholar 

  120. Hogg RE, Woodside JV, McGrath A, Young IS, Vioque JL, Chakravarthy U et al (2017) Mediterranean diet score and its association with age-related macular degeneration: the European Eye Study. Ophthalmology 124(1):82–89

    Article  PubMed  Google Scholar 

  121. Merle BM, Silver RE, Rosner B, Seddon JM (2015) Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study. Am J Clin Nutr 102(5):1196–1206

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Chong EW, Guymer RH, Robman LD (2014) Does aspirin increase the risk of age-related macular degeneration? Expert Opin Drug Saf 13(6):691–693

    CAS  PubMed  Google Scholar 

  123. Christen WG, Glynn RJ, Chew EY, Buring JE (2009) Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology 116(12):2386–2392

    Article  PubMed  Google Scholar 

  124. Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Chew EY, Buring JE et al (2001) Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. Arch Ophthalmol 119(8):1143–1149

    Article  CAS  PubMed  Google Scholar 

  125. Rim TH, Yoo TK, Kwak J, Lee JS, Kim SH, Kim DW et al (2018) Long-term regular use of low-dose aspirin and neovascular age-related macular degeneration: National Sample Cohort 2010-2015. Ophthalmology. https://doi.org/10.1016/j.ophtha.2018.09.014

  126. Al-Holou SN, Tucker WR, Agron E, Clemons TE, Cukras C, Ferris FL 3rd et al (2015) The association of statin use with age-related macular degeneration progression: the Age-Related Eye Disease Study 2 report number 9. Ophthalmology 122(12):2490–2496

    Article  PubMed  Google Scholar 

  127. Aldebert G, Faillie JL, Hillaire-Buys D, Mura T, Carriere I, Delcourt C et al (2018) Association of anticholinergic drug use with risk for late age-related macular degeneration. JAMA Ophthalmol 136(7):770–778

    Article  PubMed  PubMed Central  Google Scholar 

  128. Keenan TD, Goldacre R, Goldacre MJ (2017) Associations between obstructive sleep apnoea, primary open angle glaucoma and age-related macular degeneration: record linkage study. Br J Ophthalmol 101(2):155–159

    Article  PubMed  Google Scholar 

  129. Schaal S, Sherman MP, Nesmith B, Barak Y (2016) Untreated obstructive sleep apnea hinders response to Bevacizumab in age-related macular degeneration. Retina 36(4):791–797

    Article  CAS  PubMed  Google Scholar 

  130. McGuinness MB, Le J, Mitchell P, Gopinath B, Cerin E, Saksens NTM et al (2017) Physical activity and age-related macular degeneration: a systematic literature review and meta-analysis. Am J Ophthalmol 180:29–38

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, MD, USA

    Tiarnán D. L. Keenan, Catherine A. Cukras & Emily Y. Chew

Authors
  1. Tiarnán D. L. Keenan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Catherine A. Cukras
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emily Y. Chew
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tiarnán D. L. Keenan .

Editor information

Editors and Affiliations

  1. Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, MD, USA

    Emily Y. Chew

  2. Neurobiology-Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, MD, USA

    Anand Swaroop

Rights and permissions

Reprints and permissions

Copyright information

© 2021 This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Keenan, T.D.L., Cukras, C.A., Chew, E.Y. (2021). Age-Related Macular Degeneration: Epidemiology and Clinical Aspects. In: Chew, E.Y., Swaroop, A. (eds) Age-related Macular Degeneration. Advances in Experimental Medicine and Biology, vol 1256. Springer, Cham. https://doi.org/10.1007/978-3-030-66014-7_1

Download citation

Publish with us

Policies and ethics

Search

Navigation